UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7026
Stereotaxis
STXS
$135M
| $30.4K | ﹤0.01% |
16,730
-4,951
| -23% | -$11.1K |
|
7027
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.27B
| $30.4K | ﹤0.01% |
+407
| New | +$29.3K |
|
7028
ALPS Dynamic US Dividend Advantage ETF
RFDA
$89M
| $30.4K | ﹤0.01% |
575
+340
| +145% | +$17.3K |
|
|
QTEX
7029
QTREX Quantum
QTEX
$59.1M
| $30.4K | ﹤0.01% |
+22,037
| New | +$43K |
|
7030
Innovative Eyewear
LUCY
$6.19M
| $30.4K | ﹤0.01% |
+3,070
| New | +$22K |
|
|
SFYX
7031
DELISTED
SoFi Next 500 ETF
SFYX
| $30.4K | ﹤0.01% |
+2,280
| New | +$30.7K |
|
|
EDN
7032
Edenor
EDN
$1.09B
| $30.3K | ﹤0.01% |
1,851
-29
| -2% | -$509 |
|
7033
Boxlight
BOXL
$2.2M
| $30.3K | ﹤0.01% |
275
-100
| -27% | -$11.6K |
|
7034
Nuveen ESG 1-5 Year US Aggregate Bond ETF
NUSA
$34.5M
| $30.1K | ﹤0.01% |
1,315
+1,314
| +131,400% | +$29.9K |
|
7035
Banco Macro
BMA
$5.51B
| $30.1K | ﹤0.01% |
525
-668
| -56% | -$38.3K |
|
7036
The Future Fund Active ETF
FFND
$104M
| $30.1K | ﹤0.01% |
+1,281
| New | +$29.1K |
|
7037
SCYNEXIS
SCYX
$51.6M
| $30K | ﹤0.01% |
+1,875
| New | +$29K |
|
7038
Swan Hedged Equity US Large Cap ETF
HEGD
$726M
| $29.9K | ﹤0.01% |
1,407
+1,149
| +445% | +$23.7K |
|
|
SOPA
7039
DELISTED
Society Pass
SOPA
| $29.9K | ﹤0.01% |
22,500
+19,920
| +772% | +$36.6K |
|
7040
Forafric Global
AFRI
$284M
| $29.9K | ﹤0.01% |
2,799
-2,850
| -50% | -$30.4K |
|
7041
Galectin Therapeutics
GALT
$212M
| $29.8K | ﹤0.01% |
+13,207
| New | +$40.1K |
|
|
GB
7042
DELISTED
Global Blue Group Holding
GB
| $29.8K | ﹤0.01% |
+6,191
| New | +$30.9K |
|
7043
KULR Technology Group
KULR
$128M
| $29.8K | ﹤0.01% |
9,429
+8,070
| +594% | +$28.9K |
|
|
IMAQ
7044
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
| $29.8K | ﹤0.01% |
2,566
+2,494
| +3,464% | +$28.7K |
|
7045
Jowell Global
JWEL
$3.87M
| $29.7K | ﹤0.01% |
14,347
+13,252
| +1,210% | +$19.1K |
|
7046
ProShares UltraPro S&P 500
UPRO
$5.6B
| $29.6K | ﹤0.01% |
385
-66
| -15% | -$4.58K |
|
7047
Tilly's
TLYS
$126M
| $29.6K | ﹤0.01% |
4,902
-18,450
| -79% | -$107K |
|
7048
John Hancock Multifactor Emerging Markets ETF
JHEM
$1.01B
| $29.5K | ﹤0.01% |
+1,105
| New | +$29.3K |
|
|
MAGN
7049
Magnera Corp
MAGN
$446M
| $29.5K | ﹤0.01% |
1,634
-3,055
| -65% | -$65.8K |
|
7050
Transcontinental Realty Investors
TCI
$347M
| $29.5K | ﹤0.01% |
1,063
-280
| -21% | -$8.43K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.